PRELUDE CAPITAL MANAGEMENT, LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 166 filers reported holding REPLIGEN CORP in Q2 2014. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q1 2023$398,171
+0.1%
2,365
+0.6%
0.02%
+14.3%
Q4 2022$397,879
-41.7%
2,350
-8.9%
0.02%
+16.7%
Q4 2021$683,000
-17.7%
2,579
-10.2%
0.02%
-14.3%
Q3 2021$830,000
+41.9%
2,872
-2.0%
0.02%
+23.5%
Q2 2021$585,000
+162.3%
2,932
+152.3%
0.02%
+183.3%
Q4 2020$223,000
+1758.3%
1,162
+617.3%
0.01%
+500.0%
Q3 2019$12,000
-20.0%
162
-6.4%
0.00%0.0%
Q2 2019$15,000
+400.0%
173
+284.4%
0.00%
Q1 2019$3,000
-50.0%
45
-58.7%
0.00%
Q4 2018$6,000
-94.8%
109
-97.4%
0.00%
-100.0%
Q2 2016$116,000
+127.5%
4,258
+124.1%
0.02%
+128.6%
Q1 2016$51,000
-28.2%
1,900
-24.0%
0.01%
-36.4%
Q4 2015$71,000
+34.0%
2,500
+31.6%
0.01%
+37.5%
Q3 2015$53,000
-14.5%
1,900
+26.7%
0.01%
-11.1%
Q2 2015$62,000
-24.4%
1,500
-44.4%
0.01%
-18.2%
Q1 2015$82,000
-46.1%
2,700
-64.9%
0.01%
-50.0%
Q4 2014$152,000
+6.3%
7,700
+6.9%
0.02%
+10.0%
Q3 2014$143,000
-50.9%
7,200
-43.6%
0.02%
-47.4%
Q2 2014$291,000
+172.0%
12,755
+52.9%
0.04%
+153.3%
Q1 2014$107,000
+161.0%
8,341
+125.4%
0.02%
+114.3%
Q3 2013$41,0003,7000.01%
Other shareholders
REPLIGEN CORP shareholders Q2 2014
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders